Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

  • Authors : Koopman ADM; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, HV Amsterdam, the Netherlands.; Beulens JW

Subjects: Insulin Resistance*; Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

  • Source: Calcified tissue international [Calcif Tissue Int] 2019 Jun; Vol. 104 (6), pp. 599-604. Date of Electronic Publication: 2019 Jan 24.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

  • Authors : Peters KE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*blood

  • Source: Diabetes care [Diabetes Care] 2017 Nov; Vol. 40 (11), pp. 1548-1555. Date of Electronic Publication: 2017 Aug 29.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.

  • Authors : Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

×
Academic Journal

Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.

  • Authors : Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, MA. Electronic address: .

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/blood

  • Source: American heart journal [Am Heart J] 2024 May; Vol. 271, pp. 38-47. Date of Electronic Publication: 2024 Feb 22.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

×
Academic Journal

Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.

  • Authors : Yu MK; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Vart P

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

  • Source: Journal of general internal medicine [J Gen Intern Med] 2024 May; Vol. 39 (6), pp. 921-930. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

  • Source: Diabetologia [Diabetologia] 2024 May; Vol. 67 (5), pp. 837-849. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease.

  • Authors : Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia (B.L.N.).; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia (B.L.N.).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Circulation [Circulation] 2024 Apr 16; Vol. 149 (16), pp. 1238-1240. Date of Electronic Publication: 2024 Apr 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study.

  • Authors : Ziser KED; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Wood S

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use

  • Source: Journal of diabetes [J Diabetes] 2024 Apr; Vol. 16 (4), pp. e13507.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print Cited

Record details

×
Academic Journal

Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.

  • Authors : Heerspink HJ; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; The George Institute for Global Health, Sydney, New South Wales, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: American heart journal [Am Heart J] 2024 Apr; Vol. 270, pp. 125-135. Date of Electronic Publication: 2024 Feb 15.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

×
  • 1-10 of  8,475 results for "%22AUSTRALIA%22"